BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH; Apheresis Applications Committee of the American Society for Apheresis. Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2010;25:83-177. [PMID: 20568098 DOI: 10.1002/jca.20240] [Cited by in Crossref: 366] [Cited by in F6Publishing: 303] [Article Influence: 33.3] [Reference Citation Analysis]
Number Citing Articles
1 Sato D, Callegaro D, Lana-peixoto MA, Fujihara K. Treatment of neuromyelitis optica: an evidence based review. Arq Neuro-Psiquiatr 2012;70:59-66. [DOI: 10.1590/s0004-282x2012000100012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
2 Daniele N, Del Proposto G, Cerrone P, Sinopoli S, Sansone L, Gadaleta DI, Lanti A, Ferraro AS, Spurio S, Scerpa MC, Zinno F, Adorno G, Isacchi G. Evaluation of cell death after treatment with extracorporeal photopheresis. Transfusion and Apheresis Science 2012;46:53-7. [DOI: 10.1016/j.transci.2011.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Winters JL. Apheresis in the treatment of idiopathic dilated cardiomyopathy. J Clin Apheresis 2012;27:312-9. [DOI: 10.1002/jca.21245] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jeffus S, Wehrli G. Blood banking and transfusion medicine for the apheresis medicine practitioner. J Clin Apher 2012;27:160-7. [PMID: 22532095 DOI: 10.1002/jca.21226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Raciti PM, Francis RO, Spitalnik PF, Schwartz J, Jhang JS. Acquired hemoglobin variants and exposure to glucose-6-phosphate dehydrogenase deficient red blood cell units during exchange transfusion for sickle cell disease in a patient requiring antigen-matched blood. J Clin Apher 2013;28:325-9. [PMID: 23450789 DOI: 10.1002/jca.21255] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
6 Mohammadi S, Malek Mohammadi A, Norooznezhad AH, Heshmati F, Alimoghaddam K, Ghavamzadeh A. Extra corporeal photochemotherapy in steroid refractory graft versus host disease: A review of guidelines and recommendations. Transfus Apher Sci 2017;56:376-84. [PMID: 28359604 DOI: 10.1016/j.transci.2017.01.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
7 Ibrahim RB, Balogun RA. Medications in patients treated with therapeutic plasma exchange: prescription dosage, timing, and drug overdose. Semin Dial. 2012;25:176-189. [PMID: 22321259 DOI: 10.1111/j.1525-139x.2011.01030.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
8 Sampley S, Sakhuja V, Bhasin D, Singh K, Singh H. Plasmapheresis for Pulmonary Hemorrhage Following Viperine Snakebite: A Case Report with Review of Literature. Indian J Crit Care Med 2020;24:986-90. [PMID: 33281328 DOI: 10.5005/jp-journals-10071-23635] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yoo S, Lee EY, Huh KH, Kim MS, Kim YS, Kim HO. Role of plasma exchange in ABO-incompatible kidney transplantation. Ann Lab Med 2012;32:283-8. [PMID: 22779070 DOI: 10.3343/alm.2012.32.4.283] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
10 Jaben EA, Torloni AS, Pruthi RK, Winters JL. Use of plasma exchange in patients with heparin-induced thrombocytopenia: A report of two cases and a review of the literature: PE in HIT. J Clin Apheresis 2011;26:219-24. [DOI: 10.1002/jca.20289] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
11 Leitner GC, Vogelsang H. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J Gastrointest Pharmacol Ther 2016; 7(1): 5-20 [PMID: 26855808 DOI: 10.4292/wjgpt.v7.i1.5] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
12 Douglas K. Experience with Apheresis Procedures After Plerixafor Mobilisation. In: Fruehauf S, Zeller WJ, Calandra G, editors. Novel Developments in Stem Cell Mobilization. Boston: Springer US; 2012. pp. 133-63. [DOI: 10.1007/978-1-4614-1960-0_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Pham HP, Williams LA. Therapeutic plasma exchange in two patients with stiff-person syndrome: TPE in Stiff-Person Syndrome. J Clin Apheresis 2016;31:493-4. [DOI: 10.1002/jca.21431] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 Jaksch P, Knobler R. ECP and solid organ transplantation. Transfus Apher Sci. 2014;50:358-362. [PMID: 24768429 DOI: 10.1016/j.transci.2014.04.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
15 Bottari G, Di Nardo M, Gleeson J, Minoia F, Moscatelli A, Cecchetti C, Verrina EE. Extracorporeal blood purification techniques in children with hyper-inflammatory syndromes: a clinical overview. Minerva Anestesiol 2019;85. [DOI: 10.23736/s0375-9393.19.13189-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
16 Schellongowski P, Staudinger T. [Leukostasis and tumor lysis: important complications of hyperleukocytosis]. Internist (Berl) 2013;54:1051-60. [PMID: 23943008 DOI: 10.1007/s00108-013-3260-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Pandit TN, Sarode R. Blood component support in acquired coagulopathic conditions: Is there a method to the madness? Am J Hematol 2012;87:S56-62. [DOI: 10.1002/ajh.23179] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
18 De Simone N, Racsa L, Bevan S, Matevosyan K, Valley T, Girod C, Sarode R. Therapeutic plasma exchange in the management of sepsis and multiple organ dysfunction syndrome: A report of three cases: Plasma Exchange in MODS. J Clin Apheresis 2014;29:127-31. [DOI: 10.1002/jca.21296] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
19 Şavk E, Uslu M, Yavaşoğlu I, Kadıköylü G, Şendur N, Karaman G. Resistant oral mucosal lesions in pemphigus vulgaris responsive to double filtration plasmapheresis: First case report from Turkey. Transfusion and Apheresis Science 2013;48:273-5. [DOI: 10.1016/j.transci.2013.01.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
20 Liu CT, Chen TH, Cheng CY. Successful treatment of drug-induced acute liver failure with high-volume plasma exchange. J Clin Apher. 2013;28:430-434. [PMID: 23922237 DOI: 10.1002/jca.21291] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
21 Bambauer R, Latza R, Burgard D, Schiel R. Therapeutic Apheresis in Immunologic Renal and Neurological Diseases. Ther Apher Dial 2017;21:6-21. [PMID: 28078733 DOI: 10.1111/1744-9987.12499] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Morgan SM, Shaz BH, Pavenski K, Meyer EK, Delaney M, Szczepiorkowski ZM. The top clinical trial opportunities in therapeutic apheresis and neurology: Top Trial Opportunities in TA and Neurology. J Clin Apheresis 2014;29:331-5. [DOI: 10.1002/jca.21339] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
23 Louw VJ, Nel MM, Hay JF. Factors affecting the current status of transfusion medicine education in South Africa. Transfusion and Apheresis Science 2013;49:665-72. [DOI: 10.1016/j.transci.2013.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
24 Hunt EA, Jain NG, Somers MJ. Apheresis therapy in children: An overview of key technical aspects and a review of experience in pediatric renal disease: Apheresis Therapy in Children. J Clin Apheresis 2013;28:36-47. [DOI: 10.1002/jca.21260] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
25 Adamski J, Hanna CA, Reddy VB, Litovsky SH, Evans CA, Marques MB. Multiorgan failure and bone marrow necrosis in three adults with sickle cell-β+ -thalassemia. Am J Hematol 2012;87:621-4. [PMID: 22374850 DOI: 10.1002/ajh.23117] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
26 Auer-Hackenberg L, Winkler S, Graninger W, Worel N, Ramharter M. Current evidence and future of automated erythrocyte exchange in the treatment of severe malaria. Wien Klin Wochenschr 2012;124 Suppl 3:23-6. [PMID: 23064860 DOI: 10.1007/s00508-012-0238-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
27 Keklik M, Sivgin S, Kaynar L, Pala C, Solmaz M, Cetin M, Eser B, Unal A. Treatment with plasma exchange may serve benefical effect in patients with severe hyperbilirubinemia: a single center experience. Transfus Apher Sci 2013;48:323-6. [PMID: 23602141 DOI: 10.1016/j.transci.2013.04.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
28 Kong SG, Seo JH, Jun SE, Lee BK, Lim YT. Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation. Blood Res 2014;49:29-35. [PMID: 24724064 DOI: 10.5045/br.2014.49.1.29] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
29 Carhill A, Gutierrez A, Lakhia R, Nalini R. Surviving The Storm: Two Cases Of Thyroid Storm Successfully Treated With Plasmapheresis. BMJ Case Rep. 2012;2012. [PMID: 23087271 DOI: 10.1136/bcr-2012-006696] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
30 Thompson G, Parhofer KG. Current Role of Lipoprotein Apheresis. Curr Atheroscler Rep 2019;21:26. [PMID: 31041550 DOI: 10.1007/s11883-019-0787-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
31 Szczepiorkowski ZM. Indications for therapeutic apheresis in hematological disorders. Semin Hematol 2020;57:57-64. [PMID: 32892844 DOI: 10.1053/j.seminhematol.2020.07.008] [Reference Citation Analysis]
32 Dzenkeviciute V, Skujaite A, Rinkuniene E, Petrulioniene Z, Gumbiene L, Katkiene S, Laucevicius A. Pregnancy-related severe hypertriglyceridemia. Clinical Lipidology 2015;10:299-304. [DOI: 10.2217/clp.15.25] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Bouchard J, Roberts DM, Roy L, Ouellet G, Decker BS, Mueller BA, Desmeules S, Ghannoum M. Principles and operational parameters to optimize poison removal with extracorporeal treatments. Semin Dial 2014;27:371-80. [PMID: 24824059 DOI: 10.1111/sdi.12247] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.9] [Reference Citation Analysis]
34 Schutt RC, Ronco C, Rosner MH. The role of therapeutic plasma exchange in poisonings and intoxications. Semin Dial 2012;25:201-6. [PMID: 22353434 DOI: 10.1111/j.1525-139X.2011.01033.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
35 Hassaniazad M, Vahedi MS, Samimagham HR, Gharibzadeh A, Beyranvand S, Abbasi H, Nikpoor AR. Improvement of clinical outcome, laboratory findings and inflammatory cytokines levels using plasmapheresis therapy in severe COVID-19 cases. Respir Med 2021;189:106669. [PMID: 34757278 DOI: 10.1016/j.rmed.2021.106669] [Reference Citation Analysis]
36 Kadikoylu G, Yavasoglu I, Ozkul A, Akyol A, Yukselen V, Guney E, Bolaman Z. The single center registry for therapeutic apheresis in Turkey: 11-year activity. Transfusion and Apheresis Science 2012;47:61-5. [DOI: 10.1016/j.transci.2012.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
37 Stegmayr B, Ramlow W, Balogun RA. Beyond Dialysis: Current and Emerging Blood Purification Techniques: CURRENT AND EMERGING BLOOD PURIFICATION TECHNIQUES. Seminars in Dialysis 2012;25:207-13. [DOI: 10.1111/j.1525-139x.2011.01034.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
38 Garbaini J, Rao P, Lal D, Caltabiano MJ, Shi PA, Shaz BH. Current patterns of use in therapeutic apheresis: a metropolitan center experience: Letters to the Editor. Transfusion 2014;54:1899-900. [DOI: 10.1111/trf.12685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Okafor C, Kalantarinia K. Vascular Access Considerations for Therapeutic Apheresis Procedures: VASCULAR ACCESS CONSIDERATIONS. Seminars in Dialysis 2012;25:140-4. [DOI: 10.1111/j.1525-139x.2011.01024.x] [Cited by in Crossref: 13] [Article Influence: 1.3] [Reference Citation Analysis]
40 Witt V, Beiglböck E, Fritsch G. Bone marrow processing with the AMICUS™ separator system: Bone Marrow Processing AMICUS™ System. J Clin Apheresis 2011;26:195-9. [DOI: 10.1002/jca.20293] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
41 Yilmaz D, Karapinar B, Karadaş N, Duyu M, Yazici P, Ay Y, Balkan C, Aydinok Y, Kavakli K. Leukapheresis in Childhood Acute Leukemias: Single-Center Experience. Pediatric Hematology and Oncology 2013;31:318-26. [DOI: 10.3109/08880018.2013.818747] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
42 Petras ML, Dunbar NM, Filiano JJ, Braga MS, Chobanian MC, Szczepiorkowski ZM. Therapeutic plasma exchange in Streptococcus pneumoniae-associated hemolytic uremic syndrome: a case report.J Clin Apher. 2012;27:212-214. [PMID: 22307916 DOI: 10.1002/jca.21208] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
43 Martino M, Fedele R, Cornelio G, Moscato T, Imbalzano L, Ressa G, Massara E, Bresolin G. Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art. Expert Opin Biol Ther 2012;12:1017-30. [PMID: 22587646 DOI: 10.1517/14712598.2012.688025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
44 Seth A, Rajpal S, Saigal T, Bienvenu J, Sheth A, Alexander JS, Boktor M, Manas K, Morris JD, Jordan PA. Diabetic Ketoacidosis-induced Hypertriglyceridemic Acute Pancreatitis Treated with Plasmapheresis-Recipe for Biochemical Disaster Management. Clin Med Insights Gastroenterol 2014;7:51-3. [PMID: 25342924 DOI: 10.4137/CGast.S18557] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
45 Pham HP, Schwartz J. Therapeutic Leukocytapheresis and Adsorptive Cytapheresis. Transfusion Medicine and Hemostasis. Elsevier; 2013. pp. 511-4. [DOI: 10.1016/b978-0-12-397164-7.00076-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Hadem J, Hafer C, Schneider AS, Wiesner O, Beutel G, Fuehner T, Welte T, Hoeper MM, Kielstein JT. Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients. BMC Anesthesiol 2014;14:24. [PMID: 24708653 DOI: 10.1186/1471-2253-14-24] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
47 Ramírez-Bueno A, Salazar-Ramírez C, Cota-Delgado F, de la Torre-Prados MV, Valdivielso P. Plasmapheresis as treatment for hyperlipidemic pancreatitis. Eur J Intern Med 2014;25:160-3. [PMID: 24012324 DOI: 10.1016/j.ejim.2013.08.701] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
48 Khatri BO, Kramer J, Dukic M, Palencia M, Verre W. Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica. J Clin Apheresis 2012;27:183-92. [DOI: 10.1002/jca.21215] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
49 Beştepe Dursun Z, Korkmaz S, Türe Z, Kaynar L, Dursun A, Çelik İ. Efficacy of therapeutic plasma exchange in patients with Crimean-Congo hemorrhagic fever. J Clin Apher 2021;36:390-7. [PMID: 33485278 DOI: 10.1002/jca.21875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Das-Gupta E, Dignan F, Shaw B, Raj K, Malladi R, Gennery A, Bonney D, Taylor P, Scarisbrick J. Extracorporeal photopheresis for treatment of adults and children with acute GVHD: UK consensus statement and review of published literature. Bone Marrow Transplant 2014;49:1251-8. [PMID: 24887389 DOI: 10.1038/bmt.2014.106] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
51 Li A, Pavenski K, Kuo KHM, Patriquin CJ. Apheresis education in Canadian residency programs: A needs assessment. Transfus Apher Sci 2020;59:102780. [PMID: 32505439 DOI: 10.1016/j.transci.2020.102780] [Reference Citation Analysis]
52 Mishra R, Cano E, Venkatram S, Diaz-Fuentes G. An interesting case of mycoplasma pneumonia associated multisystem involvement and diffuse alveolar hemorrhage. Respir Med Case Rep 2017;21:78-81. [PMID: 28413775 DOI: 10.1016/j.rmcr.2017.03.022] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
53 Patel N, Bayliss GP. Developments in extracorporeal therapy for the poisoned patient. Advanced Drug Delivery Reviews 2015;90:3-11. [DOI: 10.1016/j.addr.2015.05.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
54 Rolfes L, Pfeuffer S, Ruck T, Melzer N, Pawlitzki M, Heming M, Brand M, Wiendl H, Meuth SG. Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs-A Systematic Review. J Clin Med 2019;8:E1623. [PMID: 31590282 DOI: 10.3390/jcm8101623] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
55 Sinha A, Tiwari AN, Chanchlani R, Seetharamanjaneyulu V, Hari P, Bagga A. Therapeutic plasmapheresis using membrane plasma separation. Indian J Pediatr 2012;79:1084-6. [PMID: 22766901 DOI: 10.1007/s12098-012-0779-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
56 Lavelle JC, Karp JK. Myositis is a category IV indication for plasmapheresis. J Clin Apher 2015;30:257-8. [PMID: 25346339 DOI: 10.1002/jca.21365] [Reference Citation Analysis]
57 Koziolek MJ, Kitze B, Mühlhausen J, Müller GA. Immunoadsorption in steroid-refractory multiple sclerosis. Atherosclerosis Supplements 2013;14:175-8. [DOI: 10.1016/j.atherosclerosissup.2012.10.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
58 Li Y, Qiu Z, Huang L, Cao C. Extracorporeal membrane oxygenation combined with sequential blood purification in the treatment of myocardial damage and cardiac arrest caused by mushroom poisoning. Toxicon 2021;197:65-9. [PMID: 33872678 DOI: 10.1016/j.toxicon.2021.04.011] [Reference Citation Analysis]
59 Kleess LE, Janicic N. SEVERE HYPERTRIGLYCERIDEMIA IN PREGNANCY: A CASE REPORT AND REVIEW OF THE LITERATURE. AACE Clin Case Rep 2019;5:e99-e103. [PMID: 31967011 DOI: 10.4158/ACCR-2018-0168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
60 Pumerantz AW, Stout BJ, Tracy CL. Granulomatosis With Polyangiitis Presenting as Acute Compartment Syndrome. J Clin Rheumatol 2016;22:225-8. [PMID: 27219317 DOI: 10.1097/RHU.0000000000000407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Winters JL. Randomized controlled trials in therapeutic apheresis: Randomized Trials in Apheresis. J Clin Apheresis 2013;28:48-55. [DOI: 10.1002/jca.21263] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
62 Okoroiwu HU, Okafor IM. Demographic characteristics of blood and blood components transfusion recipients and pattern of blood utilization in a tertiary health institution in southern Nigeria. BMC Hematol 2018;18:16. [PMID: 30079249 DOI: 10.1186/s12878-018-0112-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
63 Özdemir ZC, Bör Ö, Dinleyici EÇ, Kıral E. Plasmapheresis in a child with cold antibody autoimmune hemolytic anemia: case report. Turk Pediatri Ars 2017;52:169-72. [PMID: 29062252 DOI: 10.5152/TurkPediatriArs.2017.2956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Kim YA, Sloan SR. Pediatric Therapeutic Apheresis. Pediatric Clinics of North America 2013;60:1569-80. [DOI: 10.1016/j.pcl.2013.08.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
65 Watanaboonyongcharoen P, Park YA, Poisson JL, Brecher ME. Rapid increases in parasitemia following red cell exchange for malaria. J Clin Apher 2011;26:315-9. [PMID: 21964823 DOI: 10.1002/jca.20309] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
66 Dyer M, Neal MD, Rollins-raval MA, Raval JS. Simultaneous extracorporeal membrane oxygenation and therapeutic plasma exchange procedures are tolerable in both pediatric and adult patients: Simultaneous ECMO and Plasma Exchange. Transfusion 2014;54:1158-65. [DOI: 10.1111/trf.12418] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
67 Reddy SK, Jahan A, Chaturvedi S, Agarwal I. Plasma exchange for paediatric kidney disease-indications and outcomes: a single-centre experience. Clin Kidney J 2015;8:702-7. [PMID: 26613028 DOI: 10.1093/ckj/sfv084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
68 Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, Dunbar NM, Witt V, Wu Y, Shaz BH. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher. 2016;31:149-162. [PMID: 27322218 DOI: 10.1002/jca.21470] [Cited by in Crossref: 168] [Cited by in F6Publishing: 211] [Article Influence: 42.0] [Reference Citation Analysis]
69 Schmid D, Grabmer C, Streif D, Lener T, Schallmoser K, Rohde E. T‐Cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy. Vox Sang 2014;108:82-8. [DOI: 10.1111/vox.12200] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
70 Barcellini W, Fattizzo B, Zaninoni A. Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives. J Blood Med 2019;10:265-78. [PMID: 31496855 DOI: 10.2147/JBM.S190327] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
71 Nguyen TC. Thrombocytopenia-Associated Multiple Organ Failure. Crit Care Clin 2020;36:379-90. [PMID: 32172819 DOI: 10.1016/j.ccc.2019.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
72 Negi G, Talekar MS, Verma SK, Rehmani B, Gupta V, Agarwal A, Harsh M. Therapeutic platelet reduction: Use in postsplenectomy thrombocytosis. Asian J Transfus Sci 2015;9:85-6. [PMID: 25722581 DOI: 10.4103/0973-6247.150961] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
73 Shi L, Hu F, Xu C, Zhu H, Qie D, Yuan C, Tao Y, Liu H. Plasma exchange successfully treated macrophage activation syndrome in rheumatoid factor-positive polyarticular juvenile idiopathic arthritis with co-existing pneumonia. Int J Rheum Dis 2018;21:1142-5. [PMID: 28328098 DOI: 10.1111/1756-185X.13064] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Bambauer R, Latza R, Burgard D, Schiel R. Therapeutic Apheresis in Hematologic, Autoimmune and Dermatologic Diseases With Immunologic Origin. Ther Apher Dial 2016;20:433-52. [PMID: 27633388 DOI: 10.1111/1744-9987.12474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
75 Cahalane AM, Smith MJ, Ryan J, Maguire D. Acute pancreatitis secondary to gestational hypertriglyceridaemia. Case Rep Med 2012;2012:627890. [PMID: 22844296 DOI: 10.1155/2012/627890] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
76 Gehrie EA, Coberly EA, Treml A, Tormey C, Booth GS. What is the evidence to support the use of plasma exchange as first-line therapy for N-methyl d-aspartate receptor antibody encephalitis? J Clin Apher 2018;33:126-7. [PMID: 28699649 DOI: 10.1002/jca.21567] [Reference Citation Analysis]
77 Berentsen S. Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease. Semin Hematol 2018;55:141-9. [PMID: 30032751 DOI: 10.1053/j.seminhematol.2018.04.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
78 Clark SL, Rabinstein AA. Safety of intravenous immunoglobulin and plasma exchange in critically ill patients. Neurol Res 2015;37:593-8. [PMID: 25751423 DOI: 10.1179/1743132815Y.0000000017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
79 Winters JL. Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines. Hematology 2012;2012:7-12. [DOI: 10.1182/asheducation.v2012.1.7.3797920] [Cited by in Crossref: 78] [Article Influence: 8.7] [Reference Citation Analysis]
80 Weiss PF, Klink AJ, Friedman DF, Feudtner C. Pediatric therapeutic plasma exchange indications and patterns of use in us children's hospitals. J Clin Apheresis 2012;27:287-94. [DOI: 10.1002/jca.21242] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
81 Seyedali S, Alpert DR. Longitudinal extensive transverse myelitis: a rare neurological complication of systemic lupus erythematosus. BMJ Case Rep 2019;12:e228950. [PMID: 31028050 DOI: 10.1136/bcr-2018-228950] [Reference Citation Analysis]
82 Goglin S, Chung SA. Current Treatment of Cryoglobulinemic Vasculitis. Curr Treat Options in Rheum 2016;2:213-24. [DOI: 10.1007/s40674-016-0048-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
83 Tombak A, Uçar MA, Akdeniz A, Yilmaz A, Kaleagası H, Sungur MA, Tiftik EN. Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases. Indian J Hematol Blood Transfus 2017;33:97-105. [PMID: 28194064 DOI: 10.1007/s12288-016-0661-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
84 Goldstein SL, Klaus G, Friedman DF, Friedman DF, Kim HC. Pediatric Therapeutic Apheresis. In: Warady BA, Schaefer F, Alexander SR, editors. Pediatric Dialysis. Boston: Springer US; 2012. pp. 775-96. [DOI: 10.1007/978-1-4614-0721-8_41] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
85 Nguyen TC, Carcillo JA. Therapeutic plasma exchange as a strategy to reverse multiple organ dysfunction syndrome in patients receiving extracorporeal life support. Pediatr Crit Care Med 2015;16:383-5. [PMID: 25946266 DOI: 10.1097/PCC.0000000000000372] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
86 Jhang JS, Schwartz J. Phlebotomy or bloodletting: from tradition to evidence-based medicine: EDITORIAL. Transfusion 2012;52:460-2. [DOI: 10.1111/j.1537-2995.2012.03548.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
87 Sato DK, Lana-peixoto MA, Fujihara K, de Seze J. Clinical Spectrum and Treatment of Neuromyelitis Optica Spectrum Disorders: Evolution and Current Status: Clinical Spectrum and Treatment of NMO/NMOSD. Brain Pathology 2013;23:647-60. [DOI: 10.1111/bpa.12087] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
88 Basu S, Dhar S, Mishra D, Chandy M. Clinico-serologic co-relation in bi-directional ABO incompatible hemopoietic stem cell transplantation. Asian J Transfus Sci 2015;9:181-4. [PMID: 26420941 DOI: 10.4103/0973-6247.154257] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
89 Bellone M, Chiang J, Ahmed T, Galanakis D, Senzel L. Thrombotic thrombocytopenic purpura and its look-alikes: A single institution experience. Transfusion and Apheresis Science 2012;46:59-64. [DOI: 10.1016/j.transci.2011.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
90 Pignalosa O, Infante T, Napoli C. The use of therapeutic apheresis in cardiovascular disease: Therapeutic apheresis in cardiovascular disease. Transfusion Med 2014;24:68-78. [DOI: 10.1111/tme.12103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
91 Ward DM. Conventional apheresis therapies: a review. J Clin Apher. 2011;26:230-238. [PMID: 21882233 DOI: 10.1002/jca.20302] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 7.3] [Reference Citation Analysis]
92 C Leitner G, Worel N, Vogelsang H. Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease. Transfus Med Hemother 2012;39:246-52. [PMID: 22969694 DOI: 10.1159/000341801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
93 Muller C, Perrin P, Faller B, Richter S, Chantrel F. Role Of Plasma Exchange In The Thyroid Storm. Ther Apher Dial. 2011;15:522-531. [PMID: 22107688 DOI: 10.1111/j.1744-9987.2011.01003.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
94 Diana JS, Manceau S, Rabeony T, Elie C, Jolaine V, Zamora S, Aubart M, Salvi N, Bodemer C, Bader-Meunier B, Barnerias C, Iserin F, Chardot C, Lacaille F, Renolleau S, Salomon R, Joseph L, Cavazzana M, Lefrere F, Dupic L, Delville M. Therapeutic plasma exchange for life-threatening pediatric disorders. J Clin Apher 2021. [PMID: 34469617 DOI: 10.1002/jca.21934] [Reference Citation Analysis]
95 Dietrich JW. [Thyroid storm]. Med Klin Intensivmed Notfmed 2012;107:448-53. [PMID: 22878518 DOI: 10.1007/s00063-012-0113-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
96 Sharma RR, Saluja K, Jain A, Dhawan HK, Thakral B, Marwaha N. Scope and application of therapeutic apheresis: Experience from a tertiary care hospital in North India. Transfus Apher Sci 2011;45:239-45. [PMID: 22036963 DOI: 10.1016/j.transci.2011.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
97 Quintero OL, Rojas-villarraga A, Mantilla RD, Anaya J. Autoimmune diseases in the intensive care unit. An update. Autoimmunity Reviews 2013;12:380-95. [DOI: 10.1016/j.autrev.2012.06.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
98 Berentsen S. New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. Front Immunol 2020;11:590. [PMID: 32318071 DOI: 10.3389/fimmu.2020.00590] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 20.0] [Reference Citation Analysis]
99 Walsh M. Plasma exchange in antineutrophil cytoplasm antibody-associated vasculitis. Curr Opin Nephrol Hypertens. 2014;23:555-559. [PMID: 25144513 DOI: 10.1097/mnh.0000000000000058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Hill QA, Stamps R, Massey E, Grainger JD, Provan D, Hill A; British Society for Haematology. The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol 2017;176:395-411. [PMID: 28005293 DOI: 10.1111/bjh.14478] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 15.2] [Reference Citation Analysis]
101 Bruserud Ø, Liseth K, Stamnesfet S, Cacic DL, Melve G, Kristoffersen E, Hervig T, Reikvam H. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia. Transfus Med 2013;23:397-406. [PMID: 23919332 DOI: 10.1111/tme.12067] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
102 Koh H, Kaushik M, Loh JK, Chng CL. Plasma exchange and early thyroidectomy in thyroid storm requiring extracorporeal membrane oxygenation. Endocrinol Diabetes Metab Case Rep 2019;2019:1-6. [PMID: 31352696 DOI: 10.1530/EDM-19-0051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Hequet O, Stocco V, Assari S, Drillat P, Le QH, Kassir A, Rigal D, Bouzgarrou R. Comparison of plasma exchange performances between Spectra Optia and COBE Spectra apheresis systems in repeated procedures considering variability and using specific statistical models. Transfus Apher Sci 2014;51:47-53. [PMID: 25130725 DOI: 10.1016/j.transci.2014.07.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
104 Simabukuro MM, Watanabe RGS, Pinto LF, Guariglia C, Gonçalves DCME, Anghinah R. A successful case of anti-NMDAR encephalitis without tumor treated with a prolonged regimen of plasmapheresis. Dement Neuropsychol 2014;8:87-9. [PMID: 29213885 DOI: 10.1590/S1980-57642014DN81000014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
105 Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M, Mata P, Parhofer KG, Raal FJ, Santos RD, Sijbrands EJ, Simpson WG, Sullivan DR, Susekov AV, Tomlinson B, Wiegman A, Yamashita S, Kastelein JJ. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. Journal of Clinical Lipidology 2014;8:148-72. [DOI: 10.1016/j.jacl.2014.01.002] [Cited by in F6Publishing: 63] [Reference Citation Analysis]
106 Wu HC, Lee LC, Wang WJ. Plasmapheresis for hypertriglyceridemia: The association between blood viscosity and triglyceride clearance rate. J Clin Lab Anal 2019;33:e22688. [PMID: 30320483 DOI: 10.1002/jcla.22688] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
107 Lee B, Choi Y, Han HS, Yoon YS, Cho JY, Jeong SH, Kim JW, Jang ES, Ahn S. ABO-incompatible liver transplantation using only rituximab for patients with low anti-ABO antibody titer. Ann Hepatobiliary Pancreat Surg 2019;23:211-8. [PMID: 31501808 DOI: 10.14701/ahbps.2019.23.3.211] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Szczepiorkowski ZM, Burnett CA, Dumont LJ, Abhyankar SH. Apheresis buffy coat collection without photoactivation has no effect on apoptosis, cell proliferation, and total viability of mononuclear cells collected using photopheresis systems. Transfusion 2018;58:943-50. [PMID: 29451308 DOI: 10.1111/trf.14532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
109 Auer-Hackenberg L, Staudinger T, Bojic A, Locker G, Leitner GC, Graninger W, Winkler S, Ramharter M, Worel N. Automated red blood cell exchange as an adjunctive treatment for severe Plasmodium falciparum malaria at the Vienna General Hospital in Austria: a retrospective cohort study. Malar J 2012;11:158. [PMID: 22564543 DOI: 10.1186/1475-2875-11-158] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
110 Davis AL, Carcillo JA, Aneja RK, Deymann AJ, Lin JC, Nguyen TC, Okhuysen-Cawley RS, Relvas MS, Rozenfeld RA, Skippen PW. American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock. Crit Care Med. 2017;45:1061-1093. [PMID: 28509730 DOI: 10.1097/ccm.0000000000002425] [Cited by in Crossref: 238] [Cited by in F6Publishing: 100] [Article Influence: 59.5] [Reference Citation Analysis]
111 Weinstein R, Kershaw G, Bailey J, Greene M, Chhibber V, Vauthrin M, Nath R, Galvin Karr E. Safety and efficacy of autologous hemopoietic progenitor cell collection in tandem with hemodialysis in multiple myeloma with myeloma cast nephropathy. J Clin Apher 2014;29:83-9. [PMID: 23959911 DOI: 10.1002/jca.21295] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
112 Giammarco S, Chiusolo P, Piccirillo N, Di Giovanni A, Metafuni E, Laurenti L, Sica S, Pagano L. Hyperleukocytosis and leukostasis: management of a medical emergency. Expert Review of Hematology 2017;10:147-54. [DOI: 10.1080/17474086.2017.1270754] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
113 Bastiaans DE, van Uden IW, Ruiterkamp RA, de Jong BA. Removal of valproic acid by plasmapheresis in a patient treated for multiple sclerosis. Ther Drug Monit 2013;35:1-3. [PMID: 23222689 DOI: 10.1097/FTD.0b013e31827b1cfa] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
114 Cozzi F, Marson P, Cardarelli S, Favaro M, Tison T, Tonello M, Pigatto E, De Silvestro G, Punzi L, Doria A. Prognosis of scleroderma renal crisis: a long-term observational study. Nephrology Dialysis Transplantation 2012;27:4398-403. [DOI: 10.1093/ndt/gfs317] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
115 Košt́ál M, Bláha M, Lánská M, Košt́álová M, Bláha V, Štepánová E, Malý J. Beneficial effect of plasma exchange in the treatment of toxic epidermal necrolysis: A series of four cases. J Clin Apheresis 2012;27:215-20. [DOI: 10.1002/jca.21213] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
116 Cortina G, McRae R, Chiletti R, Butt W. Therapeutic Plasma Exchange in Critically Ill Children Requiring Intensive Care. Pediatr Crit Care Med 2018;19:e97-e104. [PMID: 29401139 DOI: 10.1097/PCC.0000000000001400] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
117 Johnson M, Parnham A, Ralph D. Priapism: A rare initial presentation for chronic lymphocytic leukaemia. Journal of Clinical Urology 2018;11:66-7. [DOI: 10.1177/2051415817720355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
118 Vinan-Vega M, Mantilla B, Jahan N, Peminda C, Nugent K, Lado-Abeal J, Rivas A. Usefulness of plasmapheresis in patients with severe complicated thyrotoxicosis. Proc (Bayl Univ Med Cent) 2020;34:279-82. [PMID: 33678963 DOI: 10.1080/08998280.2020.1852007] [Reference Citation Analysis]
119 Scherer J, Singh VP, Pitchumoni CS, Yadav D. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol. 2014;48:195-203. [PMID: 24172179 DOI: 10.1097/01.mcg.0000436438.60145.5a] [Cited by in Crossref: 194] [Cited by in F6Publishing: 161] [Article Influence: 27.7] [Reference Citation Analysis]
120 De Santis GC, de Oliveira LCO, Romano LGM, Almeida Prado BDP, Simoes BP, Rego EM, Covas DT, Falcao RP. Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia: Leukapheresis in Patients with Leukostasis. J Clin Apheresis 2011;26:181-5. [DOI: 10.1002/jca.20290] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
121 Poisson JL, Low A, Park YA. The treatment of nephrogenic systemic fibrosis with therapeutic plasma exchange: Treatment of Nephrogenic Systemic Fibrosis With TPE. J Clin Apheresis 2013;28:317-20. [DOI: 10.1002/jca.21253] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
122 Post GR, James L, Alapat D, Guillory V, Cottler-fox M, Nakagawa M. A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange. Transfusion and Apheresis Science 2013;48:35-8. [DOI: 10.1016/j.transci.2012.06.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
123 Kaya E, Keklik M, Şencan M, Yilmaz M, Keskin A, Kiki İ, Erkurt MA, Şivgin S, Korkmaz S, Okan V, Doğu MH, Ünal A, Çetin M, Altuntaş F, Ilhan O. Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis. Transfusion and Apheresis Science 2013;48:349-52. [DOI: 10.1016/j.transci.2013.04.015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
124 Rizzo C, Rizzo S, Scirè E, Di Bona D, Ingrassia C, Franco G, Bono R, Quintini G, Caruso C. Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange. Blood Transfus 2012;10:521-32. [PMID: 22790258 DOI: 10.2450/2012.0122-11] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
125 Russi G, Marson P. Urgent plasma exchange: how, where and when. Blood Transfus 2011;9:356-61. [PMID: 21839014 DOI: 10.2450/2011.0093-10] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
126 Zhang Y, He W, He C, Wan J, Lin X, Zheng X, Li L, Li X, Yang X, Yu B, Xian X, Zhu Y, Wang Y, Liu G, Lu N. Large triglyceride-rich lipoproteins in hypertriglyceridemia are associated with the severity of acute pancreatitis in experimental mice. Cell Death Dis 2019;10:728. [PMID: 31570698 DOI: 10.1038/s41419-019-1969-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
127 Röllig C, Ehninger G. How I treat hyperleukocytosis in acute myeloid leukemia. Blood 2015;125:3246-52. [DOI: 10.1182/blood-2014-10-551507] [Cited by in Crossref: 88] [Cited by in F6Publishing: 71] [Article Influence: 14.7] [Reference Citation Analysis]
128 Kamran Mirza M, Pogoriler J, Paral K, Ananthanarayanan V, Mandal S, Mazin A, Baron B, Richa E. Adjunct therapeutic plasma exchange for anti-N-methyl-D-aspartate receptor antibody encephalitis: A case report and review of literature. J Clin Apheresis 2011;26:362-5. [DOI: 10.1002/jca.20312] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
129 van Wijk DF, Sjouke B, Figueroa A, Emami H, van der Valk FM, Macnabb MH, Hemphill LC, Schulte DM, Koopman MG, Lobatto ME, Verberne HJ, Fayad ZA, Kastelein JJ, Mulder WJ, Hovingh GK, Tawakol A, Stroes ES. Nonpharmacological Lipoprotein Apheresis Reduces Arterial Inflammation in Familial Hypercholesterolemia. Journal of the American College of Cardiology 2014;64:1418-26. [DOI: 10.1016/j.jacc.2014.01.088] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 9.4] [Reference Citation Analysis]
130 Herath N, Wazil A, Kularatne S, Ratnatunga N, Weerakoon K, Badurdeen S, Rajakrishna P, Nanayakkara N, Dharmagunawardane D. Thrombotic microangiopathy and acute kidney injury in hump-nosed viper (Hypnale species) envenoming: a descriptive study in Sri Lanka. Toxicon 2012;60:61-5. [PMID: 22483846 DOI: 10.1016/j.toxicon.2012.03.015] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
131 Codron P, Cousin M, Subra J, Pautot V, Letournel F, Verny C, Cassereau J. Therapeutic plasma exchange in chronic dysimmune peripheral neuropathies: A 10-year retrospective study. J Clin Apher 2017;32:413-22. [DOI: 10.1002/jca.21530] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
132 Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenmüller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, Münte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Schöcklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellhöner P, Wiesner M, Zeissig S, Büning J, Schiffer M, Kuehbacher T; EHEC-HUS consortium. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 2012;345:e4565. [PMID: 22815429 DOI: 10.1136/bmj.e4565] [Cited by in Crossref: 203] [Cited by in F6Publishing: 164] [Article Influence: 22.6] [Reference Citation Analysis]
133 Nguyen TC, Cruz MA, Carcillo JA. Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury. Crit Care Clin 2015;31:661-74. [PMID: 26410136 DOI: 10.1016/j.ccc.2015.06.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
134 Veljković D, Kuzmanović M, Mićić D, Šerbić-Nonković O. Leukapheresis in management hyperleucocytosis induced complications in two pediatric patients with chronic myelogenous leukemia. Transfus Apher Sci 2012;46:263-7. [PMID: 22480956 DOI: 10.1016/j.transci.2012.03.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
135 Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104: H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant. 2012;27:3807-3815. [PMID: 23114903 DOI: 10.1093/ndt/gfs394] [Cited by in Crossref: 159] [Cited by in F6Publishing: 130] [Article Influence: 19.9] [Reference Citation Analysis]
136 Gadó K, Z Szabó L, Csákó L, Domján G. [Wegener's granulomatosis]. Orv Hetil 2013;154:1083-95. [PMID: 23835353 DOI: 10.1556/OH.2013.29666] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
137 Ono Y, Ono S, Yasunaga H, Matsui H, Fushimi K, Tanaka Y. Factors Associated With Mortality of Thyroid Storm: Analysis Using a National Inpatient Database in Japan. Medicine (Baltimore) 2016;95:e2848. [PMID: 26886648 DOI: 10.1097/MD.0000000000002848] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
138 Alfadhli E, Gianoukakis AG. Management of severe thyrotoxicosis when the gastrointestinal tract is compromised. Thyroid 2011;21:215-20. [PMID: 21254909 DOI: 10.1089/thy.2010.0159] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
139 Dumortier J, Scoazec JY, Guillaud O, Hequet O, Hervieu V, Boillot O. Treatment of severe refractory de novo auto-immune hepatitis after liver transplantation with plasmapheresis. Clin Res Hepatol Gastroenterol. 2015;39:e83-e85. [PMID: 26070570 DOI: 10.1016/j.clinre.2015.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
140 Momtaz M, Fayed A, Marzouk K, Shaker A. Therapeutic Plasma Exchange Outcomes in Cairo University Hospitals: 6 Years Experience: Cairo University Plasma Exchange Outcome. Ther Apher Dial 2018;22:666-73. [DOI: 10.1111/1744-9987.12710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
141 Benidt GR, Jaben EA, Winters JL, Stubbs JR. Identification of anti-PP1Pk in a blood donor and her family: A case report following her pregnancy and review. Transfusion and Apheresis Science 2010;43:369-74. [DOI: 10.1016/j.transci.2010.10.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
142 Rudingwa P, Senthilnathan M, Suganya S, Panneerselvam S. Intraoperative acute hematuria: Sole clue to mismatch transfusion. Asian J Transfus Sci 2019;13:63-5. [PMID: 31360015 DOI: 10.4103/ajts.AJTS_153_17] [Reference Citation Analysis]
143 Wehrli G. Blood banking and transfusion medicine for the nephrologist. Semin Dial 2012;25:114-8. [PMID: 22276991 DOI: 10.1111/j.1525-139X.2011.01021.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
144 Menne J, Kielstein J, Wenzel U, Stahl R. Therapie des typischen hämolytisch-urämischen Syndroms: Erkenntnisse aus dem E.-coli-Ausbruch 2011. Internist 2012;53:1420-30. [DOI: 10.1007/s00108-012-3107-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
145 Barcellini W, Fattizzo B, Zaninoni A. Current and emerging treatment options for autoimmune hemolytic anemia. Expert Rev Clin Immunol 2018;14:857-72. [PMID: 30204521 DOI: 10.1080/1744666X.2018.1521722] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
146 Winters JL, Brown D, Hazard E, Chainani A, Andrzejewski C Jr. Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome. BMC Health Serv Res 2011;11:101. [PMID: 21575219 DOI: 10.1186/1472-6963-11-101] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
147 Schulz M, Bug G, Bialleck H, Serve H, Seifried E, Bönig H. Leucodepletion for hyperleucocytosis--first report on a novel technology featuring electronic interphase management. Vox Sang 2013;105:47-53. [PMID: 23384315 DOI: 10.1111/vox.12020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
148 Stefanutti C, Julius U. Lipoprotein apheresis: State of the art and novelties. Atherosclerosis Supplements 2013;14:19-27. [DOI: 10.1016/j.atherosclerosissup.2012.10.021] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
149 Hölig K, Moog R. Leukocyte Depletion by Therapeutic Leukocytapheresis in Patients with Leukemia. Transfus Med Hemother 2012;39:241-5. [PMID: 22969693 DOI: 10.1159/000341805] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
150 Pons-estel GJ, Salerni GE, Serrano RM, Gomez-puerta JA, Plasin MA, Aldasoro E, Lozano M, Cid J, Cervera R, Espinosa G. Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: Report of 31 cases and review of the literature. Autoimmunity Reviews 2011;10:679-84. [DOI: 10.1016/j.autrev.2011.04.028] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
151 Winters JL. Lipid apheresis, indications, and principles. J Clin Apheresis 2011;26:269-75. [DOI: 10.1002/jca.20299] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
152 Cid J, Elena M, Diekmann F, Lozano M. Haptoglobin is present in albumin used as a replacement solution for plasma exchange: HAPTOGLOBIN AND PLASMA EXCHANGE. Transfusion 2013;53:757-60. [DOI: 10.1111/j.1537-2995.2012.03783.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
153 Stefanutti C, Gozzer M, Pisciotta L, D'Eufemia P, Bosco G, Morozzi C, Papadia F, Shafii M, Di Giacomo S, Bertolini S. A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment. Atheroscler Suppl 2013;14:73-6. [PMID: 23357145 DOI: 10.1016/j.atherosclerosissup.2012.10.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
154 Betz C, Buettner S, Geiger H, Jung O. Regional Citrate Anticoagulation in Therapeutic Plasma Exchange with Fresh Frozen Plasma - a Modified Protocol. Int J Artif Organs 2013;36:803-11. [DOI: 10.5301/ijao.5000245] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
155 Winters JL, Burgstaler EA, Gottschall JL, Balogun RA, Houghton JR, Lee WJ, Snyder EL. A multicenter evaluation of a new therapeutic plasma exchange procedure. Transfusion 2013;53:3269-78. [PMID: 23581280 DOI: 10.1111/trf.12189] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
156 Tobian AA, Shirey RS, King KE. ABO antibody titer monitoring for incompatible renal transplantation: EDITORIAL. Transfusion 2011;51:454-7. [DOI: 10.1111/j.1537-2995.2011.03049.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
157 Stefanutti C, Labbadia G, Morozzi C. Severe hypertriglyceridemia-related acute pancreatitis. Ther Apher Dial. 2013;17:130-137. [PMID: 23551669 DOI: 10.1111/1744-9987.12008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 6.6] [Reference Citation Analysis]
158 Wang Y, Attar BM, Abu Omar Y, Agrawal R, Demetria MV. Pseudohyponatremia in Hypertriglyceridemia-Induced Acute Pancreatitis: A Tool for Diagnosis Rather Than Merely a Laboratory Error? Pancreas 2019;48:126-30. [DOI: 10.1097/mpa.0000000000001192] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Tarr PI, Karpman D. Editorial commentary: Escherichia coli O104:H4 and hemolytic uremic syndrome: the analysis begins. Clin Infect Dis 2012;55:760-3. [PMID: 22670035 DOI: 10.1093/cid/cis533] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
160 Nguyen TC, Kiss JE, Goldman JR, Carcillo JA. The role of plasmapheresis in critical illness. Crit Care Clin 2012;28:453-68, vii. [PMID: 22713617 DOI: 10.1016/j.ccc.2012.04.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
161 Zengin S, Yilmaz M, Al B, Yildirim C, Yarbil P, Kilic H, Bozkurt S, Kose A, Bayraktaroglu Z. Plasma exchange as a complementary approach to snake bite treatment: An academic emergency department’s experiences. Transfusion and Apheresis Science 2013;49:494-8. [DOI: 10.1016/j.transci.2013.03.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
162 Mccarthy A, Dineen J, Mckenna P, Keogan M, Sheehan J, Lynch T, O’rourke K. Anti-NMDA receptor encephalitis with associated catatonia during pregnancy. J Neurol 2012;259:2632-5. [DOI: 10.1007/s00415-012-6561-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
163 Raab S, Klingenstein M, Liebau S, Linta L. A Comparative View on Human Somatic Cell Sources for iPSC Generation. Stem Cells Int. 2014;2014:768391. [PMID: 25431601 DOI: 10.1155/2014/768391] [Cited by in Crossref: 112] [Cited by in F6Publishing: 104] [Article Influence: 16.0] [Reference Citation Analysis]
164 Bajantri B, Sapkota B, Venkatram S. Diffuse Alveolar Hemorrhage without Extrapulmonary Manifestations: A Rare Presentation of Lupus. Am J Case Rep 2018;19:218-23. [PMID: 29487279 DOI: 10.12659/ajcr.907148] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
165 Winters JL; American Society for Apheresis. American Society for Apheresis guidelines on the use of apheresis in clinical practice: practical, concise, evidence-based recommendations for the apheresis practitioner. J Clin Apher 2014;29:191-3. [PMID: 24890667 DOI: 10.1002/jca.21334] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
166 Holzer FJ, Seeck M, Korff CM. Autoimmunity and inflammation in status epilepticus: from concepts to therapies. Expert Rev Neurother 2014;14:1181-202. [PMID: 25201402 DOI: 10.1586/14737175.2014.956457] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
167 Deng J, Zhou F, Wong CY, Huang E, Zheng E. Efficacy of therapeutic plasma exchange for treatment of autoimmune hemolytic anemia: A systematic review and meta‐analysis of randomized controlled trials. J Clin Apher 2020;35:294-306. [DOI: 10.1002/jca.21790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
168 Li F, Chen AB, Duan YC, Liao R, Xu YW, Tao LL. Multiple organ dysfunction and rhabdomyolysis associated with moonwort poisoning: Report of four cases. World J Clin Cases 2020; 8(2): 479-486 [PMID: 32047801 DOI: 10.12998/wjcc.v8.i2.479] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 O'brien KL, Price TH, Howell C, Delaney M. The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura: Fifty Percent Albumin/Plasma Fluid for TPE in TTP. J Clin Apheresis 2013;28:416-21. [DOI: 10.1002/jca.21288] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
170 Staley EM, Schwartz J, Pham HP. An update on ABO incompatible hematopoietic progenitor cell transplantation. Transfus Apher Sci 2016;54:337-44. [PMID: 27211814 DOI: 10.1016/j.transci.2016.05.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
171 Morgan SM, Zantek ND. Therapeutic plasma exchange for fulminant hepatic failure secondary to Wilson's disease. J Clin Apheresis 2012;27:282-6. [DOI: 10.1002/jca.21239] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
172 Nichols L, Berg A, Rollins-raval MA, Raval JS. Cardiac Injury Is a Common Postmortem Finding in Thrombotic Thrombocytopenic Purpura Patients: Is Empiric Cardiac Monitoring and Protection Needed?: Autopsy Findings in TTP Patients. Ther Apher Dial 2015;19:87-92. [DOI: 10.1111/1744-9987.12191] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
173 Maitta RW, Choate J, Emre SH, Luczycki SM, Wu Y. Emergency ABO-incompatible liver transplant secondary to fulminant hepatic failure: outcome, role of TPE and review of the literature. J Clin Apher 2012;27:320-9. [PMID: 22833397 DOI: 10.1002/jca.21244] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
174 Estridge R, Iskander M. Understanding Guillain-Barré syndrome. Journal of the American Academy of Physician Assistants 2015;28:19-22. [DOI: 10.1097/01.jaa.0000466585.10595.f5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
175 Worel N, Leitner G. Clinical Results of Extracorporeal Photopheresis. Transfus Med Hemother 2012;39:254-62. [PMID: 22969695 DOI: 10.1159/000341811] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
176 Michot J, Driss F, Guitton C, Moh Klaren J, Lefebvre F, Chamillard X, Gallon P, Fourn E, Pela AM, Tertian G, Le Bras P, Chantalat-auger C, Delfraissy J, Goujard C, Lambotte O. Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease: Tolerance of Erythrocytapheresis. Transfusion 2015;55:357-63. [DOI: 10.1111/trf.12875] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
177 Ninchoji T, Nozu K, Nakanishi K, Horinouchi T, Fujimura J, Yamamura T, Minamikawa S, Ishimori S, Nakanishi K, Yoshikawa N, Morioka I, Kaito H, Iijima K. Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience. Clin Exp Nephrol 2017;21:889-94. [PMID: 28074307 DOI: 10.1007/s10157-016-1376-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
178 Ouellet G, Bouchard J, Ghannoum M, Decker BS. Available extracorporeal treatments for poisoning: overview and limitations. Semin Dial 2014;27:342-9. [PMID: 24697909 DOI: 10.1111/sdi.12238] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
179 Ko H, Maymani H, Rojas-Hernandez C. Hemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature. J Med Case Rep 2016;10:175. [PMID: 27301547 DOI: 10.1186/s13256-016-0970-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
180 Tiwari AK, Bhardwaj G, Aggarwal G, Arora D, Dara RC, Acharya DP, Gayam S, Choudhuri J. Changing Trends in Therapeutic Plasmapheresis: An Indian Perspective: Changing Trends in TA. Ther Apher Dial 2017;21:500-6. [DOI: 10.1111/1744-9987.12549] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
181 Wong EC, Balogun RA. Therapeutic apheresis in pediatrics: Technique adjustments, indications and nonindications, a plasma exchange focus. J Clin Apheresis 2012;27:132-7. [DOI: 10.1002/jca.21224] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
182 Katcher HL. Studies that shed new light on aging. Biochemistry (Mosc). 2013;78:1061-1070. [PMID: 24228929 DOI: 10.1134/s0006297913090137] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
183 Ahmed T, Senzel L. The role of therapeutic apheresis in the treatment of acute antibody-mediated kidney rejection. J Clin Apheresis 2012;27:173-7. [DOI: 10.1002/jca.21211] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
184 Bozkirli DE, Kozanoglu I, Bozkirli E, Yucel E. Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis. J Clin Apher 2013;28:422-5. [PMID: 23908096 DOI: 10.1002/jca.21285] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
185 Chhibber V, Weinstein R. Evidence-Based Review of Therapeutic Plasma Exchange in Neurological Disorders: THERAPEUTIC PLASMA EXCHANGE IN NEUROLOGICAL DISORDERS. Seminars in Dialysis 2012;25:132-9. [DOI: 10.1111/j.1525-139x.2011.01023.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
186 Huang RS, Tholpady A, Wahed A, Chang B, Bai Y. Therapeutic plasmapheresis and red blood cell exchange in a sickle cell trait patient with rhabdomyolysis. J Clin Apher 2012;27:342-5. [PMID: 22887576 DOI: 10.1002/jca.21247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
187 Jackups R, Canter C, Sweet SC, Mohanakumar T, Morris GP. Measurement of donor-specific HLA antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection: DSA Measurement after PEX in AMR. J Clin Apheresis 2013;28:301-8. [DOI: 10.1002/jca.21270] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
188 Pham HP, Schwartz J. How to approach an apheresis consultation using the American Society for Apheresis guidelines for therapeutic apheresis procedures. VOXS 2015;10:79-88. [DOI: 10.1111/voxs.12113] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
189 Kim SH, Kim W, Huh SY, Lee KY, Jung IJ, Kim HJ. Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels. J Clin Neurol 2013;9:36-42. [PMID: 23346159 DOI: 10.3988/jcn.2013.9.1.36] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 8.9] [Reference Citation Analysis]
190 Zantek ND, Morgan S, Zantek PF, Mair DC, Bowman RJ, Aysola A. Effect of therapeutic plasma exchange on coagulation parameters in patients on warfarin: Effect of TPE and Warfarin on Coagulation. J Clin Apheresis 2014;29:75-82. [DOI: 10.1002/jca.21294] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
191 Meyer EK, Wong EC. Pediatric Therapeutic Apheresis: A Critical Appraisal of Evidence. Transfusion Medicine Reviews 2016;30:217-22. [DOI: 10.1016/j.tmrv.2016.08.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
192 Lee HJ, Shin KH, Song D, Lee SM, Chang CL, Chu CW, Ryu JH, Lee TB, Park YM, Yang KH, Choi BH, Kim HH. Increasing use of therapeutic apheresis as a liver-saving modality. Transfus Apher Sci 2017;56:385-8. [PMID: 28366590 DOI: 10.1016/j.transci.2017.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
193 Carter CE, Benador NM. Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013. Pediatr Nephrol 2014;29:35-50. [PMID: 23812351 DOI: 10.1007/s00467-013-2479-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
194 Contreras E, de la Rubia J, Del Río-Garma J, Díaz-Ricart M, García-Gala JM, Lozano M; Grupo Español de Aféresis. [Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group]. Med Clin (Barc) 2015;144:331.e1-331.e13. [PMID: 25433791 DOI: 10.1016/j.medcli.2014.09.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
195 Joury A, Alshehri M, Mahendra A, Anteet M, Yousef MA, Khan AM. Therapeutic approaches in hypertriglyceridemia-induced acute pancreatitis: A literature review of available therapies and case series. J Clin Apher 2020;35:131-7. [PMID: 31724761 DOI: 10.1002/jca.21763] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
196 Nakanishi T, Suzuki N, Kuragano T, Nagasawa Y, Hasuike Y. Current topics in therapeutic plasmapheresis. Clin Exp Nephrol. 2014;18:41-49. [PMID: 23887747 DOI: 10.1007/s10157-013-0838-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
197 Wahl SK, Garcia A, Hagar W, Gildengorin G, Quirolo K, Vichinsky E. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions: ALLOIMMUNIZATION WITH RBC EXCHANGE. Transfusion 2012;52:2671-6. [DOI: 10.1111/j.1537-2995.2012.03659.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.7] [Reference Citation Analysis]
198 Ehler J, Koball S, Sauer M, Hickstein H, Mitzner S, Benecke R, Zettl UK. Therapeutic Plasma Exchange in Glucocorticosteroid-Unresponsive Patients With Clinically Isolated Syndrome: Plasma Exchange in Clinically Isolated Syndrome. Ther Apher Dial 2014;18:489-96. [DOI: 10.1111/1744-9987.12176] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
199 Morrison-mckell TJ, Wehrli G. A needs assessment and instrument comparison for a therapeutic apheresis medicine service. J Clin Apheresis 2012;27:146-52. [DOI: 10.1002/jca.21223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
200 Borras-novell C, García Rey E, Perez Baena LF, Jordan Garcia I, Catella Cahiz D, Cambra F. Therapeutic plasma exchange in acute disseminated encephalomyelitis in children: Use of TPE in Pediatric Patients. J Clin Apheresis 2015;30:335-9. [DOI: 10.1002/jca.21388] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
201 Erkurt MA, Kuku I, Kaya E, Ozgen U, Berber I, Koroglu M, Ozgül M. Therapeutic plasma-exchange in hematologic disease: Results from a single center in Eastern Anatolia. Transfusion and Apheresis Science 2013;48:335-9. [DOI: 10.1016/j.transci.2013.04.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
202 Sanford KW, Balogun RA. Therapeutic apheresis in critically ill patients. J Clin Apher 2011;26:249-51. [PMID: 21834079 DOI: 10.1002/jca.20304] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
203 Chekol SS, Bhatnagar B, Gojo I, Hess JR. Leukopheresis for profound hyperleukocytosis. Transfusion and Apheresis Science 2012;46:29-31. [DOI: 10.1016/j.transci.2011.10.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
204 Faissner S, Nikolayczik J, Chan A, Hellwig K, Gold R, Yoon MS, Haghikia A. Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses. J Neurol 2016;263:1092-8. [PMID: 27039388 DOI: 10.1007/s00415-016-8105-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
205 Jaben EA, Pulido JS, Pittock S, Markovic S, Winters JL. The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: a report of two cases. J Clin Apher 2011;26:356-61. [PMID: 21898575 DOI: 10.1002/jca.20310] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
206 Adorni MP, Zimetti F, Puntoni M, Bigazzi F, Sbrana F, Minichilli F, Bernini F, Ronda N, Favari E, Sampietro T. Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis. J Lipid Res 2012;53:984-9. [PMID: 22414482 DOI: 10.1194/jlr.P024810] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
207 Chang B, Tholpady A, Huang RS, Nedelcu E, Bai Y. Clinical and serological responses following plasmapheresis in bullous pemphigoid: two case reports and a review of the literature. Blood Transfus 2014;12:269-75. [PMID: 24931844 DOI: 10.2450/2014.0222-13] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
208 Zborovszky EC, Santana-Cabrera L, Ramírez Rodríguez A, Díaz Mendoza C. [Plasmapheresis in the treatment of an acute pancreatitis due to hypertriglyceridemia]. Med Clin (Barc) 2014;142:282. [PMID: 24315744 DOI: 10.1016/j.medcli.2013.10.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
209 Rimmer E, Houston BL, Kumar A, Abou-Setta AM, Friesen C, Marshall JC, Rock G, Turgeon AF, Cook DJ, Houston DS, Zarychanski R. The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis. Crit Care 2014;18:699. [PMID: 25527094 DOI: 10.1186/s13054-014-0699-2] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 12.3] [Reference Citation Analysis]
210 Wang A, Richhariya A, Gandra SR, Calimlim B, Kim L, Quek RG, Nordyke RJ, Toth PP. Systematic Review of Low-Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia. J Am Heart Assoc 2016;5:e003294. [PMID: 27385428 DOI: 10.1161/JAHA.116.003294] [Cited by in Crossref: 41] [Cited by in F6Publishing: 7] [Article Influence: 8.2] [Reference Citation Analysis]
211 Timurağaoğlu A. The role of the nurses and technicians for stem cell mobilisation and collection. Transfusion and Apheresis Science 2015;53:30-3. [DOI: 10.1016/j.transci.2015.05.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
212 Rosales A, Hofer J, Zimmerhackl L, Jungraithmayr TC, Riedl M, Giner T, Strasak A, Orth-höller D, Würzner R, Karch H; for the German-Austrian HUS Study Group. Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli–Associated Hemolytic Uremic Syndrome Due to Late-Emerging Sequelae. Clinical Infectious Diseases 2012;54:1413-21. [DOI: 10.1093/cid/cis196] [Cited by in Crossref: 102] [Cited by in F6Publishing: 80] [Article Influence: 11.3] [Reference Citation Analysis]
213 Bouchard J, Lavergne V, Roberts DM, Cormier M, Morissette G, Ghannoum M. Availability and cost of extracorporeal treatments for poisonings and other emergency indications: a worldwide survey. Nephrology Dialysis Transplantation 2017;32:699-706. [DOI: 10.1093/ndt/gfw456] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
214 Andrzejewski C, Linz W, Hofmann J, O'doherty U, Robinson RS, Arepally GM, Golden P. American society for apheresis white paper: Considerations for medical staff apheresis medicine physician credentialing and privileging. J Clin Apheresis 2012;27:330-5. [DOI: 10.1002/jca.21250] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
215 Williams ME, Balogun RA. Principles of separation: indications and therapeutic targets for plasma exchange. Clin J Am Soc Nephrol 2014;9:181-90. [PMID: 24178973 DOI: 10.2215/CJN.04680513] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 4.9] [Reference Citation Analysis]
216 Córdoba JP, Larrarte C, Ruiz A. Is anticoagulation required in plasmapheresis? A University Hospital Experience in Bogota, Colombia. Transfusion and Apheresis Science 2013;48:301-5. [DOI: 10.1016/j.transci.2013.04.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
217 Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, Pham HP, Schneiderman J, Witt V, Wu Y, Zantek ND, Dunbar NM, Schwartz GEJ. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue. J Clin Apher. 2019;34:171-354. [PMID: 31180581 DOI: 10.1002/jca.21705] [Cited by in Crossref: 314] [Cited by in F6Publishing: 281] [Article Influence: 157.0] [Reference Citation Analysis]
218 Sanchez AP, Ward DM. Therapeutic apheresis for renal disorders. Semin Dial. 2012;25:119-131. [PMID: 22428811 DOI: 10.1111/j.1525-139x.2011.01022.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
219 Ghetie D, Mehraban N, Sibley CH. Cold Hard Facts of Cryoglobulinemia. Rheumatic Disease Clinics of North America 2015;41:93-108. [DOI: 10.1016/j.rdc.2014.09.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
220 Goldstein SL. Therapeutic apheresis in children: special considerations. Semin Dial 2012;25:165-70. [PMID: 22277133 DOI: 10.1111/j.1525-139X.2011.01028.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 6] [Article Influence: 3.6] [Reference Citation Analysis]
221 Gidding SS, Champagne MA, de Ferranti SD, Defesche J, Ito MK, Knowles JW, McCrindle B, Raal F, Rader D, Santos RD, Lopes-Virella M, Watts GF, Wierzbicki AS; American Heart Association Atherosclerosis, Hypertension, and Obesity in Young Committee of Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and Council on Lifestyle and Cardiometabolic Health. The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association. Circulation 2015;132:2167-92. [PMID: 26510694 DOI: 10.1161/CIR.0000000000000297] [Cited by in Crossref: 351] [Cited by in F6Publishing: 131] [Article Influence: 58.5] [Reference Citation Analysis]
222 Song D, Wu LH, Wang FM, Yang XW, Zhu D, Chen M, Yu F, Liu G, Zhao MH. The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther. 2013;15:R12. [PMID: 23320601 DOI: 10.1186/ar4142] [Cited by in Crossref: 119] [Cited by in F6Publishing: 101] [Article Influence: 14.9] [Reference Citation Analysis]
223 Galán Carrillo I, Demelo-Rodriguez P, Rodríguez Ferrero ML, Anaya F. Double filtration plasmapheresis in the treatment of pancreatitis due to severe hypertriglyceridemia. J Clin Lipidol 2015;9:698-702. [PMID: 26350817 DOI: 10.1016/j.jacl.2015.07.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
224 Jung MK, Jin J, Kim HO, Kwon A, Chae HW, Kang SJ, Kim DH, Kim HS. A 1-month-old infant with chylomicronemia due to GPIHBP1 gene mutation treated by plasmapheresis. Ann Pediatr Endocrinol Metab 2017;22:68-71. [PMID: 28443263 DOI: 10.6065/apem.2017.22.1.68] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
225 Li C, Li H, Su W, Wen YB, Ye W, Ye WL, Cai JF, Qin XZ, Li XM, Li XW. Clinicopathological study of mixed cryoglobulinemic glomerulonephritis secondary to hepatitis B virus infection. BMC Nephrol 2020;21:395. [PMID: 32928133 DOI: 10.1186/s12882-020-02057-4] [Reference Citation Analysis]
226 Mata P, Alonso R, Ruiz A, Gonzalez-juanatey JR, Badimón L, Díaz-díaz JL, Muñoz MT, Muñiz O, Galve E, Irigoyen L, Fuentes-jiménez F, Dalmau J, Pérez-jiménez F. Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: documento de consenso. SEMERGEN - Medicina de Familia 2015;41:24-33. [DOI: 10.1016/j.semerg.2014.05.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
227 Haris Á, Arányi J, Braunitzer H, Kálmán É, Merán Z, Soltész M, Polner K. Role of plasmapheresis in immunological kidney diseases. Experience from 1050 completed plasmapheresis treatment sessions. Orvosi Hetilap 2011;152:1110-9. [DOI: 10.1556/oh.2011.29155] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
228 Chhabra A, Raj D, Choudhary PN, Grover A. Interesting case of G6PD deficiency anemia with severe hemolysis. Asian J Transfus Sci 2013;7:147-8. [PMID: 24014946 DOI: 10.4103/0973-6247.115574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
229 Yilmaz AA, Can OS, Oral M, Unal N, Ayyildiz E, Ilhan O, Tulunay M. Therapeutic plasma exchange in an intensive care unit (ICU): a 10-year, single-center experience. Transfus Apher Sci. 2011;45:161-166. [PMID: 21835700 DOI: 10.1016/j.transci.2011.04.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
230 Burstedt D, Tippett JC. Severe Hypertriglyceridemia During Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth 2019;33:3418-22. [PMID: 31076303 DOI: 10.1053/j.jvca.2019.04.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
231 Marques MB, Schwartz J. Update on extracorporeal photopheresis in heart and lung transplantation. J Clin Apheresis 2011;26:146-51. [DOI: 10.1002/jca.20274] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
232 Sanford KW, Balogun RA. Extracorporeal photopheresis: Clinical use so far. J Clin Apheresis 2012;27:126-31. [DOI: 10.1002/jca.21217] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
233 Haque A, Sher G, Hoda M, Moiz B. Feasibility of pediatric plasma apheresis in intensive care settings. Ther Apher Dial 2014;18:497-501. [PMID: 24674133 DOI: 10.1111/1744-9987.12173] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
234 Daviet F, Rouby F, Poullin P, Moussi-Francès J, Sallée M, Burtey S, Mancini J, Duffaud F, Sabatier R, Pourroy B, Grandvuillemin A, Grange S, Frémeaux-Bacchi V, Coppo P, Micallef J, Jourde-Chiche N. Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort. Br J Clin Pharmacol 2019;85:403-12. [PMID: 30394581 DOI: 10.1111/bcp.13808] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
235 Degardin J, Pons B, Ardisson F, Gallego JP, Thiery G. [Multiple organ failure complicating a severe acute necrotising pancreatitis secondary of a severe hypertriglyceridemia: a case report]. Ann Fr Anesth Reanim 2013;32:611-4. [PMID: 23948029 DOI: 10.1016/j.annfar.2013.05.010] [Reference Citation Analysis]
236 Cortina G, Ojinaga V, Giner T, Riedl M, Waldegger S, Rosales A, Trojer R, Hofer J. Therapeutic plasma exchange in children: One center's experience. J Clin Apher 2017;32:494-500. [DOI: 10.1002/jca.21547] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
237 Krause ML, Cartin-Ceba R, Specks U, Peikert T. Update on diffuse alveolar hemorrhage and pulmonary vasculitis. Immunol Allergy Clin North Am 2012;32:587-600. [PMID: 23102067 DOI: 10.1016/j.iac.2012.08.001] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
238 Parra Salinas IM, González Rodriguez VP, García-Erce JA. Therapeutic leukapheresis: 9-year experience in a University Hospital. Blood Transfus 2015;13:46-52. [PMID: 24960648 DOI: 10.2450/2014.0310-13] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
239 Keklik M, Kaynar L, Yilmaz M, Sivgin S, Solmaz M, Pala C, Aribas S, Akyol G, Unluhizarci K, Cetin M, Eser B, Unal A. The results of therapeutic plasma exchange in patients with severe hyperthyroidism: a retrospective multicenter study. Transfus Apher Sci. 2013;48:327-330. [PMID: 23611685 DOI: 10.1016/j.transci.2013.04.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
240 Sengul Samanci N, Ayer M, Gursu M, Ar MC, Yel K, Ergen A, Dogan EE, Karadag S, Cebeci E, Toptas M. Patients treated with therapeutic plasma exchange: a single center experience. Transfus Apher Sci. 2014;51:83-89. [PMID: 25457747 DOI: 10.1016/j.transci.2014.10.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
241 Barbour T, Johnson S, Cohney S, Hughes P. Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant. 2012;27:2673-2685. [PMID: 22802583 DOI: 10.1093/ndt/gfs279] [Cited by in Crossref: 121] [Cited by in F6Publishing: 91] [Article Influence: 13.4] [Reference Citation Analysis]
242 Cecchini J, Lionnet F, Djibré M, Parrot A, Stojanovic KS, Girot R, Fartoukh M. Outcomes of Adult Patients With Sickle Cell Disease Admitted to the ICU: A Case Series*. Critical Care Medicine 2014;42:1629-39. [DOI: 10.1097/ccm.0000000000000316] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
243 Mali P. Pancreatitis in pregnancy: etiology, diagnosis, treatment, and outcomes. Hepatobiliary Pancreat Dis Int. 2016;15:434-438. [PMID: 27498585 DOI: 10.1016/s1499-3872(16)60075-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
244 Sjouke B, Kusters DM, Kindt I, Besseling J, Defesche JC, Sijbrands EJ, Roeters van Lennep JE, Stalenhoef AF, Wiegman A, de Graaf J, Fouchier SW, Kastelein JJ, Hovingh GK. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome. European Heart Journal 2015;36:560-5. [DOI: 10.1093/eurheartj/ehu058] [Cited by in Crossref: 262] [Cited by in F6Publishing: 231] [Article Influence: 37.4] [Reference Citation Analysis]
245 Pham HP, Daniel-johnson JA, Stotler BA, Stephens H, Schwartz J. Therapeutic plasma exchange for the treatment of anti-NMDA receptor encephalitis. J Clin Apheresis 2011;26:320-5. [DOI: 10.1002/jca.20311] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
246 Basar R, Uzum AK, Canbaz B, Dogansen SC, Kalayoglu-Besisik S, Altay-Dadin S, Aral F, Ozbey NC. Therapeutic apheresis for severe hypertriglyceridemia in pregnancy. Arch Gynecol Obstet. 2013;287:839-843. [PMID: 23479052 DOI: 10.1007/s00404-013-2786-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
247 Szczepiorkowski ZM, Dunbar NM. Transfusion guidelines: when to transfuse. Hematology 2013;2013:638-44. [DOI: 10.1182/asheducation-2013.1.638] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
248 Kes P, Janssens ME, Bašić‐jukić N, Kljak M. A randomized crossover study comparing membrane and centrifugal therapeutic plasma exchange procedures. Transfusion 2016;56:3065-72. [DOI: 10.1111/trf.13850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
249 Mcleod BC. Plasma and plasma derivatives in therapeutic plasmapheresis: PLASMA FOR THERAPEUTIC APHERESIS. Transfusion 2012;52:38S-44S. [DOI: 10.1111/j.1537-2995.2012.03623.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
250 Acık DY, Yilmaz M, Sahin HH, Sayıner Z, Koruk I, Tiryaki O, Okan V, Pehlivan M. Management of Chenopodium polyspermum toxicity with plasma exchange and hemodialysis. J Clin Apheresis 2012;27:278-81. [DOI: 10.1002/jca.21238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
251 Gök F, Köker S, Kılıçaslan A, Sarkılar G, Yosunkaya A, Otelcioğlu Ş. Acute Pancreatitis Due to Hypertriglyceridaemia in Pregnancy. Turk J Anaesthesiol Reanim 2015;43:116-8. [PMID: 27366478 DOI: 10.5152/TJAR.2014.83435] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
252 Sjouke B, Balak DM, Beuers U, Ratziu V, Stroes ES. Is mipomersen ready for clinical implementation? A transatlantic dilemma. Curr Opin Lipidol 2013;24:301-6. [PMID: 23759796 DOI: 10.1097/MOL.0b013e328362dfd9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
253 Kim HC. Red cell exchange: special focus on sickle cell disease. Hematology Am Soc Hematol Educ Program 2014;2014:450-6. [PMID: 25696893 DOI: 10.1182/asheducation-2014.1.450] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
254 Jäger U, Barcellini W, Broome CM, Gertz MA, Hill A, Hill QA, Jilma B, Kuter DJ, Michel M, Montillo M, Röth A, Zeerleder SS, Berentsen S. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev 2020;41:100648. [PMID: 31839434 DOI: 10.1016/j.blre.2019.100648] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 27.5] [Reference Citation Analysis]
255 Chisick L, Seftel M, Kumar R. Algorithm for initial management of priapism in chronic myeloid leukaemia. Br J Haematol 2012;159:250-1. [PMID: 22924590 DOI: 10.1111/bjh.12015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
256 Pastore F, Pastore A, Wittmann G, Hiddemann W, Spiekermann K. The role of therapeutic leukapheresis in hyperleukocytotic AML. PLoS One 2014;9:e95062. [PMID: 24733550 DOI: 10.1371/journal.pone.0095062] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [Reference Citation Analysis]
257 Gonzalez-suarez M, Waheed A, Andrews D, Ascherman D, Zeng X, Nayer A. Lupus vasculopathy: Diagnostic, pathogenetic and therapeutic considerations. Lupus 2014;23:421-7. [DOI: 10.1177/0961203313520340] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
258 Lin JH, Tu KH, Chang CH, Chen YC, Tian YC, Yu CC, Hung CC, Fang JT, Yang CW, Chang MY. Prognostic factors and complication rates for double-filtration plasmapheresis in patients with Guillain-Barré syndrome. Transfus Apher Sci 2015;52:78-83. [PMID: 25544386 DOI: 10.1016/j.transci.2014.12.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
259 Schell AM, Petras M, Szczepiorkowski ZM, Ornstein DL. Refractory heparin induced thrombocytopenia with thrombosis (HITT) treated with therapeutic plasma exchange and rituximab as adjuvant therapy. Transfusion and Apheresis Science 2013;49:185-8. [DOI: 10.1016/j.transci.2013.01.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
260 Khair AM. Utility of Plasmapheresis in Autoimmune-Mediated Encephalopathy in Children: Potentials and Challenges. Neurol Res Int 2016;2016:7685807. [PMID: 27239341 DOI: 10.1155/2016/7685807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
261 Troitskaya VV, Parovichnikova EN, Sokolov AN, Kokhno AV, Kuzmina LA, Badmazhapova DS, Fidarova ZT, Gavrilina OA, Sidorova AA, Galstyan GM, Keselman SA, Gaponova TV, Galuzyak VS, Kravchenko SK, Gribanova EO, Savchenko VG. [Treatment in adult patients with acute myeloid leukemias and hyperleukocytosis at disease onset]. Ter Arkh 2015;87:33-40. [PMID: 26390723 DOI: 10.17116/terarkh201587733-40] [Reference Citation Analysis]
262 Sirinoglu Demiriz I, Tekgunduz E, Tetik A, Kayikci O, Altuntas F. Steroid refractory psoriasiform cutaneous graft versus host disease successfully treated by extracorporeal photopheresis: A case report. Transfusion and Apheresis Science 2013;48:109-11. [DOI: 10.1016/j.transci.2012.07.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
263 Bambauer R, Latza R, Bambauer C, Burgard D, Schiel R. Therapeutic apheresis in autoimmune diseases. Open Access Rheumatol 2013;5:93-103. [PMID: 27790028 DOI: 10.2147/OARRR.S34616] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
264 Gangemi S, Allegra A, Sciarrone P, Russo S, Cristani M, Gerace D, Saitta S, Alonci A, Musolino C. Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura. Eur J Haematol 2015;94:368-73. [PMID: 24813235 DOI: 10.1111/ejh.12378] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
265 Connelly-Smith L, Dunbar NM. The 2019 guidelines from the American Society for Apheresis: what's new? Curr Opin Hematol 2019;26:461-5. [PMID: 31577607 DOI: 10.1097/MOH.0000000000000534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
266 Xing Y, Wang S, Liu C, Wang H, Zhao M, Jin B, Kong X. Efficacy and safety of dual filtration plasmapheresis combined with biological agents in active refractory rheumatod arthritis: A retrospective cohort study. Medicine (Baltimore) 2020;99:e20966. [PMID: 32664100 DOI: 10.1097/MD.0000000000020966] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Ridel C, Kissling S, Mesnard L, Hertig A, Rondeau É. Échanges plasmatiques en néphrologie : techniques et indications. Néphrologie & Thérapeutique 2017;13:43-55. [DOI: 10.1016/j.nephro.2016.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
268 Alamartine E, Maillard N. Therapeutic plasma exchange in nephrology. Where it applies? Transfusion and Apheresis Science 2019;58:262-5. [DOI: 10.1016/j.transci.2019.04.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
269 Stefanutti C, Morozzi C, Di Giacomo S; Italian Multicenter Study on Low-Density Lipoprotein Apheresis Working Group. Italian multicenter study on low-density lipoprotein apheresis Working Group 2009 survey. Ther Apher Dial 2013;17:169-78. [PMID: 23551673 DOI: 10.1111/j.1744-9987.2012.01142.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
270 Mansouri Taleghani B, Buser A. Therapeutic Apheresis. Transfus Med Hemother 2019;46:391-3. [PMID: 31933568 DOI: 10.1159/000504143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
271 Paton E, Baldwin IC. Plasma exchange in the intensive care unit: a 10 year retrospective audit. Aust Crit Care. 2014;27:139-144. [PMID: 24252643 DOI: 10.1016/j.aucc.2013.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
272 Allian-sauer MU, Falko JM. Role of apheresis in the management of familial hypercholesterolemia and elevated Lp(a) levels. Clinical Lipidology 2011;6:523-38. [DOI: 10.2217/clp.11.43] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
273 Pons-estel GJ, Serrano R, Lozano M, Cid J, Cervera R, Espinosa G. Recambio plasmático en las enfermedades autoinmunes sistémicas. Seminarios de la Fundación Española de Reumatología 2013;14:43-50. [DOI: 10.1016/j.semreu.2013.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
274 Shenoy S, Shetty S, Lankala S, Anwer F, Yeager A, Adigopula S. Cardiovascular Oncologic Emergencies. Cardiology 2017;138:147-58. [PMID: 28654925 DOI: 10.1159/000475491] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
275 Blaha M, Pitha J, Blaha V, Lanska M, Maly J, Filip S, Brndiar M, Langrova H. Experience with extracorporeal elimination therapy in myasthenia gravis. Transfusion and Apheresis Science 2011;45:251-6. [DOI: 10.1016/j.transci.2011.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
276 Delmas Y, Vendrely B, Clouzeau B, Bachir H, Bui HN, Lacraz A, Hélou S, Bordes C, Reffet A, Llanas B. Outbreak of Escherichia coli O104: H4 haemolytic uraemic syndrome in France: outcome with eculizumab. Nephrol Dial Transplant. 2014;29:565-572. [PMID: 24293658 DOI: 10.1093/ndt/gft470] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 9.5] [Reference Citation Analysis]
277 Berentsen S. How I manage patients with cold agglutinin disease. Br J Haematol 2018;181:320-30. [DOI: 10.1111/bjh.15109] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 16.3] [Reference Citation Analysis]
278 Ward DM. Extracorporeal photopheresis: How, when, and why. J Clin Apheresis 2011;26:276-85. [DOI: 10.1002/jca.20300] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
279 Pierelli L, Perseghin P, Marchetti M, Messina C, Perotti C, Mazzoni A, Bacigalupo A, Locatelli F, Carlier P, Bosi A; Società Italiana di Emaferesi and Manipolazione Cellulare (SIdEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO). Extracorporeal photopheresis for the treatment of acute and chronic graft-versus-host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Tra: Recommendations for ECP in GVHD. Transfusion 2013. [DOI: 10.1111/trf.12059] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
280 Tutarel O, Golla P, Beutel G, Bauersachs J, David S, Schmidt BM, Lichtinghagen R, Kielstein JT. Therapeutic plasma exchange decreases levels of routinely used cardiac and inflammatory biomarkers. PLoS One 2012;7:e38573. [PMID: 22685586 DOI: 10.1371/journal.pone.0038573] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
281 Kolovou G, Hatzigeorgiou G, Mihas C, Gontoras N, Litras P, Devekousos D, Kontodima P, Sorontila C, Bilianou H, Mavrogeni S. Changes in Lipids and Lipoproteins after Selective LDL Apheresis (7-Year Experience). Cholesterol 2012;2012:976578. [PMID: 22315677 DOI: 10.1155/2012/976578] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
282 Connelly-smith LS, Linenberger ML. Therapeutic Apheresis for Patients with Cancer. Cancer Control 2015;22:60-78. [DOI: 10.1177/107327481502200109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
283 Cortese I, Cornblath DR. Therapeutic plasma exchange in neurology: 2012. J Clin Apher 2013;28:16-9. [PMID: 23420591 DOI: 10.1002/jca.21266] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
284 Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M, Mata P, Parhofer KG, Raal FJ, Santos RD, Sijbrands EJ, Simpson WG, Sullivan DR, Susekov AV, Tomlinson B, Wiegman A, Yamashita S, Kastelein JJ. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. International Journal of Cardiology 2014;171:309-25. [DOI: 10.1016/j.ijcard.2013.11.025] [Cited by in Crossref: 230] [Cited by in F6Publishing: 196] [Article Influence: 32.9] [Reference Citation Analysis]
285 Abeykoon JP, Yanamandra U, Kapoor P. New developments in the management of Waldenström macroglobulinemia. Cancer Manag Res 2017;9:73-83. [PMID: 28331368 DOI: 10.2147/CMAR.S94059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
286 Batra A, Periyavan S. Role of low plasma volume treatment on clinical efficacy of plasmapheresis in neuromyelitis optica. Asian J Transfus Sci 2017;11:102-7. [PMID: 28970675 DOI: 10.4103/ajts.AJTS_111_16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
287 Mata P, Alonso R, Ruiz A, Gonzalez-Juanatey JR, Badimón L, Díaz-Díaz JL, Muñoz MT, Muñiz O, Galve E, Irigoyen L, Fuentes-Jiménez F, Dalmau J, Pérez-Jiménez F; otros colaboradores. [Diagnosis and treatment of familial hypercholesterolemia in Spain: consensus document]. Aten Primaria 2015;47:56-65. [PMID: 24704195 DOI: 10.1016/j.aprim.2013.12.015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
288 Baskaran G, Tiriveedhi V, Ramachandran S, Aloush A, Grossman B, Hachem R, Mohanakumar T. Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients. J Heart Lung Transplant 2014;33:950-6. [PMID: 24906794 DOI: 10.1016/j.healun.2014.04.020] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
289 Liu L, Li X, Wang L, Yao L, Fan Q, Li Z. Successful treatment of patients with systemic lupus erythematosus complicated with autoimmune thyroid disease using double-filtration plasmapheresis: A retrospective study: DFPP for SLE Complicated With AITD. J Clin Apheresis 2011;26:174-80. [DOI: 10.1002/jca.20287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
290 Park JA. Treatment of Diffuse Alveolar Hemorrhage: Controlling Inflammation and Obtaining Rapid and Effective Hemostasis. Int J Mol Sci 2021;22:E793. [PMID: 33466873 DOI: 10.3390/ijms22020793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
291 Winters JL. Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis. J Clin Apheresis 2011;26:239-42. [DOI: 10.1002/jca.20307] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
292 Bambauer R, Bambauer C, Lehmann B, Latza R, Schiel R. LDL-apheresis: technical and clinical aspects. ScientificWorldJournal 2012;2012:314283. [PMID: 22654591 DOI: 10.1100/2012/314283] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
293 Jaben EA, Winters JL. Plasma exchange as a therapeutic option in patients with neurologic symptoms due to antibodies to voltage-gated potassium channels: a report of five cases and review of the literature. J Clin Apher. 2012;27:267-273. [PMID: 22532193 DOI: 10.1002/jca.21233] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
294 Balogun RA, Abdel-rahman EM. Therapeutic plasma exchange and renal related vasculitis: Therapeutic apheresis academy 2010. J Clin Apheresis 2011;26:291-6. [DOI: 10.1002/jca.20306] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
295 Winters JL. Low-density lipoprotein apheresis: principles and indications. Semin Dial 2012;25:145-51. [PMID: 22277063 DOI: 10.1111/j.1525-139X.2011.01025.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
296 Markota A, Knehtl M, Sinkovic A, Ekart R, Hojs R, Bevc S. Plasma exchange treatment for acute hyperlipidemic pancreatitis with falsely low levels of serum triglycerides – a case report. Transfusion and Apheresis Science 2014;51:178-80. [DOI: 10.1016/j.transci.2014.08.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
297 Chang CT, Tsai TY, Liao HY, Chang CM, Jheng JS, Huang WH, Chou CY, Chen CJ. Double Filtration Plasma Apheresis Shortens Hospital Admission Duration of Patients With Severe Hypertriglyceridemia-Associated Acute Pancreatitis. Pancreas. 2016;45:606-612. [PMID: 26491906 DOI: 10.1097/mpa.0000000000000507] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 4.4] [Reference Citation Analysis]
298 Ipe TS, Davis AR, Raval JS. Therapeutic Plasma Exchange in Myasthenia Gravis: A Systematic Literature Review and Meta-Analysis of Comparative Evidence. Front Neurol 2021;12:662856. [PMID: 34531809 DOI: 10.3389/fneur.2021.662856] [Reference Citation Analysis]
299 Hanna W, Wong HR. Pediatric sepsis: challenges and adjunctive therapies. Crit Care Clin 2013;29:203-22. [PMID: 23537672 DOI: 10.1016/j.ccc.2012.11.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
300 Huang J, Liu C, Zhu R, Su Y, Lin J, Lu J, Wen S, Zuo L. Combined usage of extracorporeal membrane oxygenation and double filtration plasmapheresis in amyopathic dermatomyositis patient with severe interstitial lung disease: A case report. Medicine (Baltimore) 2018;97:e10946. [PMID: 29851838 DOI: 10.1097/MD.0000000000010946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
301 Scott JL, Mccleskey B, Adamski J, Marques MB. Thrombotic thrombocytopenic purpura does not show seasonal variation in Alabama: Letters to the Editor. Transfusion 2013;53:1864-5. [DOI: 10.1111/trf.12253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
302 Mörtzell Henriksson M, Newman E, Witt V, Derfler K, Leitner G, Eloot S, Dhondt A, Deeren D, Rock G, Ptak J, Blaha M, Lanska M, Gasova Z, Hrdlickova R, Ramlow W, Prophet H, Liumbruno G, Mori E, Griskevicius A, Audzijoniene J, Vrielink H, Rombout S, Aandahl A, Sikole A, Tomaz J, Lalic K, Mazic S, Strineholm V, Brink B, Berlin G, Dykes J, Toss F, Axelsson CG, Stegmayr B, Nilsson T, Norda R, Knutson F, Ramsauer B, Wahlström A. Adverse events in apheresis: An update of the WAA registry data. Transfus Apher Sci 2016;54:2-15. [PMID: 26776481 DOI: 10.1016/j.transci.2016.01.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 10.4] [Reference Citation Analysis]
303 Bilir BE, Atile NS, Kirkizlar O, Kömürcü Y, Akpinar S, Sezer A, Demir M, Hekimoğlu S. Effectiveness of preoperative plasmapheresis in a pregnancy complicated by hyperthyroidism and anti-thyroid drug-associated angioedema. Gynecol Endocrinol 2013;29:508-10. [PMID: 23383744 DOI: 10.3109/09513590.2012.754871] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]